Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Martin

Showing results (531-540 of 692) with videos related to

Pageof 70
Sort By:
Cancer Medicine|July 18, 2022
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 studyAnna Maria Frezza, Silvia Stacchiotti, Frederic Chibon, et al.
Annals of the Rheumatic Diseases|December 17, 2013
Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritisMarthe T Maehlen, Inge C Olsen, Bettina K Andreassen, et al.
The Journal of Rheumatology|November 3, 2011
Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expressionJasper C A Broen, Phillipe Dieude, Madelon C Vonk, et al.
Journal of the American College of Cardiology|March 14, 2020
Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin IJasper Boeddinghaus, Thomas Nestelberger, Luca Koechlin, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 24, 2018
Circadian, weekly, seasonal, and temperature-dependent patterns of syncope aetiology in patients at increased risk of cardiac syncopeJeanne du Fay de Lavallaz, Patrick Badertscher, Thomas Nestelberger, et al.
NPJ Genomic Medicine|October 5, 2022
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosisMartin Kerick, Marialbert Acosta-Herrera, Carmen Pilar Simeón-Aznar, et al.
Cancer|March 5, 2020
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupLorenzo D'Ambrosio, Nathan Touati, Jean-Yves Blay, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 14, 2025
Distinct effects of complement C4A and C4B copy number in Systemic Sclerosis serological and clinical subtypesJavier Martínez-López, Carlos Rangel-Peláez, Inmaculada Rodriguez-Martin, et al.
Nature Reviews. Rheumatology|February 14, 2025
An international perspective on the future of systemic sclerosis researchDavid J Abraham, Carol M Black, Christopher P Denton, et al.
Journal of the American College of Cardiology|August 17, 2019
Predicting Major Adverse Events in Patients With Acute Myocardial InfarctionThomas Nestelberger, Jasper Boeddinghaus, Desiree Wussler, et al.
Pageof 70

Showing results (531-540 of 692) with videos related to

Sort By:
Pageof 70
Cancer Medicine|July 18, 2022
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 studyAnna Maria Frezza, Silvia Stacchiotti, Frederic Chibon, et al.
Annals of the Rheumatic Diseases|December 17, 2013
Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritisMarthe T Maehlen, Inge C Olsen, Bettina K Andreassen, et al.
The Journal of Rheumatology|November 3, 2011
Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expressionJasper C A Broen, Phillipe Dieude, Madelon C Vonk, et al.
Journal of the American College of Cardiology|March 14, 2020
Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin IJasper Boeddinghaus, Thomas Nestelberger, Luca Koechlin, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 24, 2018
Circadian, weekly, seasonal, and temperature-dependent patterns of syncope aetiology in patients at increased risk of cardiac syncopeJeanne du Fay de Lavallaz, Patrick Badertscher, Thomas Nestelberger, et al.
NPJ Genomic Medicine|October 5, 2022
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosisMartin Kerick, Marialbert Acosta-Herrera, Carmen Pilar Simeón-Aznar, et al.
Cancer|March 5, 2020
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupLorenzo D'Ambrosio, Nathan Touati, Jean-Yves Blay, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 14, 2025
Distinct effects of complement C4A and C4B copy number in Systemic Sclerosis serological and clinical subtypesJavier Martínez-López, Carlos Rangel-Peláez, Inmaculada Rodriguez-Martin, et al.
Nature Reviews. Rheumatology|February 14, 2025
An international perspective on the future of systemic sclerosis researchDavid J Abraham, Carol M Black, Christopher P Denton, et al.
Journal of the American College of Cardiology|August 17, 2019
Predicting Major Adverse Events in Patients With Acute Myocardial InfarctionThomas Nestelberger, Jasper Boeddinghaus, Desiree Wussler, et al.
Pageof 70